Results 101 to 110 of about 10,785 (184)

Association between triglyceride-glucose index and arteriosclerosis in patients with type 2 diabetes and its mediating effect

BMC Cardiovascular Disorders
Background To explore the relationship between the triglyceride-glucose (TyG) index and arteriosclerosis in patients with type 2 diabetes mellitus (T2DM), evaluate the direct and indirect effects of the TyG index on arteriosclerosis, and identify ...
Yan Sun, Xiaonan Shao, Xinshui Wang, Shuying Zhang   +3 more
doaj   +1 more source

Decreased level of serum carnitine might lead to arteriosclerosis progression via the accumulation of advanced glycation end products in maintenance hemodialysis patients

Renal Replacement Therapy, 2017
Background Carnitine is reported to improve insulin resistance and reduce oxidative stress. Hyperglycemia and increased oxidative stress are well known to promote the production of advanced glycation end products (AGEs) that can lead to arteriosclerosis ...
Yumi Kamada, Takashi Masuda, Kazuhiko Kotani, Shinya Tanaka, Takeshi Nakamura, Nobuaki Hamazaki, Yoko Itoh, Ibuki Moriguchi, Naoyuki Kobayashi, Michihito Okubo, Kazuhiro Takeuchi, Shokichi Naito, Yasuo Takeuchi   +12 more
doaj   +1 more source

Postprandial hypertension, an overlooked risk marker for arteriosclerosis. [PDF]

, 2012
[Objective]:Increased blood pressure (BP) variability is suggested to be a risk factor for cardiovascular disease. Although a postprandial decline in BP is a frequently observed phenomenon in the elderly, little attention has been paid to the clinical ...
Kohara, Katsuhiko, Guo, Haiyan, Igase, Michiya, Uetani, Eri, Tabara, Yasuharu, Ochi, Namiko, Miki, Tetsuro, Kido, Tomoko, Takita, Rie   +8 more
core   +1 more source

Association between Plasma Adipocytokines Levels and Intracranial versus Extracranial Atherosclerotic among Chinese Patients with Stroke

Iranian Journal of Public Health, 2020
Background: To detect the levels of plasma Adipocytokines, TNF-α, IL-6 and PAI-1 in patients with intracranial and extracranial arteriosclerosis. Methods: From September 2015 to September 2017, 318 patients aged ≥60 years were enrolled.
Chunyu LIU, Xiaodan YANG, Changqing CHEN
doaj  

EXPERIMENTAL ARTERIOSCLEROSIS [PDF]

Journal of Experimental Medicine, 1904
R M, Pearce, E M, Stanton
openaire   +2 more sources

Antiangiogenic treatment prevents adventitial constrictive remodeling in graft arteriosclerosis

, 2008
BACKGROUND Lumen loss in graft arteriosclerosis is the consequence of the development of a thick neointima and constrictive arterial remodeling. The latter is due to adventitial chronic inflammation and excessive perivascular collagen deposition.
Groyer, Emilie, Mandet, Chantal, Louedec, Liliane, Bruneval, Patrick, Dai, Jiangping, Thaunat, Olivier, Germain, Stéphane, Nicoletti, Antonino, Yacoub-Youssef, Houda, Caligiuri, Giuseppina, Graff-Dubois, Stéphanie, Michel, Jean-Baptiste, Kaveri, Srini   +12 more
core   +1 more source

Arteriosclerosis in Parkinsonism [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1964
M J, EADIE, J M, SUTHERLAND
openaire   +2 more sources

Mouse Model of Transplant Arteriosclerosis

, 2000
—Transplant-accelerated arteriosclerosis in coronary arteries is the major limitation to long-term survival of patients with heart transplantation. The pathogenesis of this disease is not fully understood. Herein, we describe a simplified model of artery
Yanhua Hu, Hermann Dietrich, Georg Wick, Qingbo Xu, Roman Kleindienst, Stephan Dirnhofer, Yiping Zou   +6 more
core   +1 more source

USO DEL POLLO COMO BIOMODELO EXPERIMENTAL EN ARTERIOSCLEROSIS [PDF]

, 2003
The most importants works on experimental atherosclerosis in chickens are described in this article. Studies of spontaneous atherosclerosis, induced atherosclerosis and also mutant models are mentioned. The most relevant experimental methods achieved are
Doménech, G., Ayala, I., Ortega, J. V., Ortega, N., García Pérez, B., Montes, A. Mª, Sánchez Polo, Mª T.   +6 more
core   +1 more source

Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients

Revista Española de Sanidad Penitenciaria
Dyslipaemia is one of the main risk factors in the development of cardiovascular diseases. Currently, there are different alternatives available (amongst which statins occupy a pre-eminent place), to optimise the treatment of patients at high or very ...
V. Pascual Fuster
doaj